Thyroid Patients Worldwide Paint Facebook Light Blue to Raise Awareness for the Undiagnosed and the Undertreated.
Current guidelines encourage the over reliance on outdated laboratory tests and ranges, as well as the prescription of synthetic thyroid hormone replacement, which is not effective in all patients. Many endocrinologists unjustifiably discourage the use of T3-containing preparations that bring relief to many suffering patients.
“For twenty-four years, synthetic levothyroxine (T4) left me with lingering symptoms,” said Michelle T. Bickford, ThyroidChange co-founder. “My physician said it wasn't from my thyroid disease, but natural desiccated thyroid has changed my life. No patient should be denied access to effective treatment by their own physician.”
Current research suggests that it is “time to consider a personalized regimen of thyroid hormone replacement therapy in hypothyroid patients,” which in this case is referring to the use of T4/T3 combination therapy. However, the 2012 Clinical Practice Guidelines of the American Association of Clinical Endocrinologists and the American Thyroid Association encourage the exclusive use of T4-only medications. Patients' experiences show that these guidelines make it difficult and often impossible for treatment-resistant thyroid patients to find effective relief, thus perpetuating their suffering.
ThyroidChange seeks to unite patient advocacy groups in an effort to gain better care for thyroid disease patients and to raise awareness of this widespread problem.
 Biondi, B. and Wartofsky, L. (2012). Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism? From http://jcem.endojournals.org/content/early/2012/05/15/jc.2011-3399.abstract
Contact via Email
|Printer friendly Cite/link Email Feedback|
|Publication:||PR.com (Press Releases)|
|Date:||Jan 8, 2013|
|Previous Article:||Luxury Home Marketing Group Announce Board Election Results, Focus for 2013.|
|Next Article:||If You Pay Anything for an iDevice Repair, You're Paying Too Much, Says David, the iSmart Guy.|